期刊文献+

降钙素基因相关肽对大鼠血管平滑肌细胞CDK2和Cyclin E的影响 被引量:6

Effect of CGRP on the CDK2 and Cyclin E of rat vascular smooth muscle cell
下载PDF
导出
摘要 目的:研究降钙素基因相关肽(CGRP)对大鼠血管平滑肌细胞中细胞周期蛋白依赖性激酶2(cyclin-dependent kinase 2,CDK2)和细胞周期蛋白E(Cyclin E)的影响,为阐明CGRP抑制血管平滑肌细胞增殖的细胞周期机制提供实验依据。方法:培养大鼠胸主动脉血管平滑肌细胞,分别用CGRP或/和10%FBS处理细胞。噻唑蓝比色法(MTT)观察CGRP对10%FBS诱导大鼠血管平滑肌细胞增殖的影响;流式细胞术分析细胞周期;Western blot检测CDK2和Cyclin E的表达。结果:CGRP能抑制10%FBS诱导的血管平滑肌细胞增殖,升高G0/G1期细胞百分比,降低S+G2+M期细胞百分比,抑制细胞内CDK2和Cyclin E表达。结论:CGRP能通过阻滞细胞周期由G0/G1期进入S期而抑制血管平滑肌细胞增殖,其作用机制可能与降低CDK2和Cyclin E表达有关。 AIM: To study the effect of calci- tonin gene-related peptide (CGRP) on cyclin-de- pendent kinase 2(CDK2) and Cyclin E of vascu- lar smooth muscle cell (VSMC), and to elute the mechanism of inhibitory effect of CGRP on proliferation of VSMC in cell cycles. METH- ODS: VSMC were prepared from thoracic aortas of male Sprague-Dawley rat by explanting meth- od. The cell viability and cell cycle were deter- mined by MTT and Flow Cytometry, respective- ly. Western Blot was used to observe expres- sions of CDK2 and Cyclin E of VSMC. RE- SULTS: Pretreatment of VSMC with CGRP nificantly inhibited cells viability, decreased slg- theproportion of S phase and increased ratio of G0/ G1 that were induced by 10% FBS, simultane-ously, CGRP down-regulated the expressions of CDK2 and Cyclin E when cultured cells with 10% FBS at 12, 24 and 48 hours. CONCLU-SION= CGRP could inhibit the cell cycle of VSMC G0/G1 phase to S phase transition, by which the mechanism maybe involved in the de-crease expressions of CDK2 and Cyclin E.
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第3期249-253,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金(30572192) 湖南省自然科学基金(05JJ30042)资助课题
关键词 降钙素基因相关肽 血管平滑肌细胞 细胞周期 细胞周期蛋依赖性激酶 细胞周期蛋白E CGRP Vascular smooth musclecell Cell cycle CDK2 Cyclin E
  • 相关文献

参考文献11

  • 1Kwasaki H, Takasaki K, Saito A, et al. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat [J]. Nature, 1988, 335(6186) :164-167.
  • 2Qin XP, Ye F, Liao DF, et al. Involvement of caleitonin gene-related peptide in the depressor effects of losartan and perindopril in rats[J].Eur J Pharmacol, 2003, 464 (1):63-67.
  • 3秦旭平,谌赟,秦又发,田海宏,孙飞.氯沙坦和哌唑嗪调节早期高血压大鼠体内降钙素基因相关肽反应的差异(英文)[J].中国临床药理学与治疗学,2009,14(1):42-47. 被引量:2
  • 4Li Y, Fiscus RR, Wu J, et al. The antiproliferative effects of caIcitonin gene-reIated peptide in different passages of cultured vascular smooth muscle cells[J]. Neuropeptides, 1997, 31(5):503-509.
  • 5Qin XP, Ye F, Hu CP, et aI. Effect of CGRP on proliferation induced by angiotensin 11 in vascular smooth muscle cells [J]. Eur J Pharmaco, 2004,488:45-49.
  • 6武旭东,徐成斌,陈红,刘秀华,陈魁,唐朝枢.降钙素基因相关肽对内皮素致血管平滑肌细胞增殖的影响[J].北京医科大学学报,1997,29(1):91-91. 被引量:15
  • 7李晓艳,黄从新,孙有刚,王晋明,王晶,王腾.降钙素基因相关肽对人血管平滑肌细胞增殖的抑制作用[J].中国病理生理杂志,2000,16(1):24-26. 被引量:21
  • 8Wang X, Wang W, Li Y, et al. Mechanism of SNAP potentiating antiproliferative effect of calcitonin gene-related peptide in cultured vascular smooth muscle cells[J]. J Mol Cell Cardiol, 1999, 31 (9):1599-- 1606.
  • 9Chattergoon NN, D Souza FM, Deng W, et al. Antiproliferative effects of calcitonin gene-related peptide in aortic and pulmonary artery smooth muscle cells [J]. Am J Physiol Lung Cell Mol Physiol, 2005, 288 (1): L202-L211.
  • 10Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression[J].Genes Dev, 1999, 13 (12):1501-1512.

二级参考文献3

共引文献35

同被引文献41

  • 1张健,蔡生业.血管平滑肌细胞表型转化及相关信号转导机制探讨[J].心血管病学进展,2005,26(2):185-189. 被引量:17
  • 2张晓一,刘玉环,廖端芳,秦旭平.Losartan和CGRP对血管紧张素Ⅱ诱导血管平滑肌细胞增殖作用的影响[J].中国药理学通报,2006,22(1):101-105. 被引量:13
  • 3秦海娜,修志龙,张代佳,包永明,李晓晖,韩国柱.PEGylation of Hirudin and Analysis of Its Antithrombin Activity in vitro[J].Chinese Journal of Chemical Engineering,2007,15(4):586-590. 被引量:14
  • 4Togni M, Windecker S, Cocchia R, et al. Siroli mus-eluting stents associated with paradoxic coro- nary vasoconstricdon[J]. J Am Coll Cardio, 2005, 46(2): 231-236.
  • 5Pasterkamp G, de Kleijn DP, Borst C. Arterial re- modeling in theroselerosis, restenosis and after al- teration of blood flow: potential mechanisms and clinical implications[J]. Cardiovasc Res, 2000, 45 (4) : 843-852.
  • 6Muto A, Fitzgerald TN, Pimiento JM, et al Smooth muscle cell signal transduction: implica tions of vascular biology for vascular surgeons[J]. J Vasc Surg, 2007, 45 (6S): 15-24.
  • 7House SJ, Potier M, Bisaillon J, et al. The non-ex citable smooth muscle., calcium signaling and phe notypic switching during vascular disease [J]. Pflugers Arch, 2008, 456 (5): 769-785.
  • 8Khachigian LM. Early growth response-1 in cardio- vascular pathobiology[J]. Circ Res, 2006, 98 (2): 186-191.
  • 9Huang Z, Shi G, Gao F, et al. Effects of N-n-butyl haloperidol iodide on L-type calcium channels and intracellular free calium in rat ventricular myocytes [J]. Bioehem Cell Biol, 2007, 85(2) : 182-188.
  • 10Huang Z, Li H, Guo F, et al. Egr-1, the potential target of calcium channel blockers in cardioprotec- tion with ischemia/reperfusion injury in rats [J]. Cell Physiol Biochem, 2009, 24(1/2): 17-24.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部